Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4.
Combinatorial synthesis and large scale screening methods are being used increasingly in drug discovery, particularly for finding novel lead compounds. Although these "random" methods sample larger areas of chemical space than traditional synthetic approaches, only a relatively small percentage of all possible compounds are practically accessible. It is therefore helpful to select regions of chemical space that have greater likelihood of yielding useful leads. When three-dimensional structural data are available for the target molecule this can be achieved by applying structure-based computational design methods to focus the combinatorial library. This is advantageous over the standard usage of computational methods to design a small number of specific novel ligands, because here computation is employed as part of the combinatorial design process and so is required only to determine a propensity for binding of certain chemical moieties in regions of the target molecule. This paper describes the application of the Multiple Copy Simultaneous Search (MCSS) method, an active site mapping and de novo structure-based design tool, to design a focused combinatorial library for the class II MHC protein HLA-DR4. Methods for the synthesizing and screening the computationally designed library are presented; evidence is provided to show that binding was achieved. Although the structure of the protein-ligand complex could not be determined, experimental results including cross-exclusion of a known HLA-DR4 peptide ligand (HA) by a compound from the library. Computational model building suggest that at least one of the ligands designed and identified by the methods described binds in a mode similar to that of native peptides.
Committee on Higher Degrees in Biophysics, Harvard University, Cambridge, MA, USA.
Erik
E
Evensen
Diane
D
Joseph-McCarthy
Gregory A
GA
Weiss
Stuart L
SL
Schreiber
Martin
M
Karplus
D000818:Animals; D001555:Benzene Derivatives / Q000737:chemistry; D001665:Binding Sites; D001713:Biphenyl Compounds / Q000737:chemistry; D020650:Combinatorial Chemistry Techniques; D016208:Databases, Factual; D015804:HLA-DR4 Antigen / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D009281:Naphthalenes / Q000737:chemistry; D012984:Software; D013237:Stereoisomerism; D013816:Thermodynamics
D001555:Benzene Derivatives; D001713:Biphenyl Compounds; D015804:HLA-DR4 Antigen; D008024:Ligands; D009281:Naphthalenes